The average one-year price target for WW International (NasdaqGM:WW) has been revised to $49.98 / share. This is an increase ...

WW International is launching a platform that integrates its wellness program with GLP-1 drugs. Should you buy the stock now?

Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2025 investor letter. A copy of the letter ...

Powerful healthcare company Eli Lilly introduced a new e-commerce platform that will surely boost sales of its new weight loss drug. Investors fear this will put a real dent in WW International's ...

One stock that has been struggling out of the gate in 2024 is WW International (NASDAQ: WW), better known as WeightWatchers. Already down more than 50% this year, it has been in a rapid free fall and ...

Yesterday was a head-spinning day in the markets. After President Donald Trump announced out of the blue that he would be placing a 90-day pause on reciprocal tariffs for many countries—excluding ...

WW International press release (NASDAQ:WW): Q4 EPS of -$1.11 may not be comparable to consensus of -$0.09. Revenue of $206M (-7.6% Y/Y) misses by $0.91M. End of Period Subscribers of 3.8 million, ...

Detailed price information for Ww International Inc (WW-Q) from The Globe and Mail including charting and trades.

The company signed a distribution deal with a big name in e-commerce. That partner will help ship its weight-management medications. Before market open that day, WW International announced it has ...

WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the industry. In the same time frame, WW has surged 66.8% compared with the ...

WW stock popped 38% on October 9 with the company revealing a new compounded semaglutide product to benefit from the current shortage of weight loss drugs in the market. The company has already ...

A prognosticator sounded a warning about the weight loss specialist. He noted that competition is increasing, and traditional dieting methods are declining in popularity. The analyst in question was ...